Brought to you by 
Auxogyn gets rights to Stanford's reproductive technology
21 Jun 2022
Executive Summary
Auxogyn Inc. (women's reproductive products) has received exclusive rights to Stanford University's technology that will enable the company to develop diagnostics to improve the effectiveness of in vitro fertilization procedures.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
Medical Devices
- Diagnostic Imaging Equipment & Supplies
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Auxogyn gets rights to Stanford's reproductive technology
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice